Posted 4/5/2024
The first conference held under the auspices of Frederick National Laboratory’s (FNL’s) Scientific Standards Hub , an...
Posted 1/25/2024
Technologies invented and patented by researchers at the Frederick National Laboratory for Cancer Research are on...
Posted 1/9/2024
Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for...
All News
Study on blood tests to guide cancer treatment to be presented at 2023 ASCO Annual Meeting
Molecular Characterization LaboratoryPosted 6/1/2023Blood-based tests that identify cancer markers may offer a non-invasive way to determine if a patient is a candidate for immunotherapy, according to a Frederick National Laboratory for Cancer Research study to be presented at the 2023 Annual Meeting of the American Society for Clinical Oncology, June 2-6 in Chicago.
Chris Karlovich, Ph.D. of the Frederick National…
Biotech Connector recap: Shedding light on human maladies
Center for Innovation and Strategic Partnerships, RAS InitiativePosted 6/1/2023Three scientists from the region presented innovative imaging techniques and discussed how they are leveraging them to advance cancer research and ultimately improve human health at the Biotech Connector seminar on Wednesday, May 17, the second in this year’s series sponsored by the Frederick National Laboratory for Cancer Research and the Frederick County Chamber of Commerce…
A single dose of HPV vaccine may provide adequate protection
Vaccine, Immunity, and Cancer DirectoratePosted 5/31/2023A growing body of evidence suggests that a single dose of vaccine against cancer-causing human papilloma virus (HPV) may protect as well as the standard two-or-more dose regimen. This would make it easier to protect more women, especially in low-income areas where vaccine access is scarce.
A study published recently in The Lancet Global Health strengthens the case, with a…
Three projects awarded LDER funding to explore innovations
Partnership Development Office, Center for Innovation and Strategic PartnershipsPosted 5/22/2023Each year, the Frederick National Laboratory offers its scientists an opportunity to compete for funding to conduct the research they view as critical to advance biomedical research but is outside the scope of their daily research activities.
This year, three proposals earned funding through the program, known as the Laboratory Directed Exploratory Research (LDER) program…
FNL joins BIO International panel to tackle tough questions about AI in oncology, promote partnerships
Center for Innovation and Strategic Partnerships, Partnership Development OfficePosted 5/19/2023
Is your billion-dollar oncology artificial intelligence (AI) cutting-edge technology, or is it artificial ignorance? That’s the question Frederick National Laboratory’s Maggie Scully, Ph.D., and a panel of industry experts seek to tackle at the BIO International Convention in Boston on June 7.
Karim Budhwani, Ph.D., DLA, CEO-scientist of CerFlux, Inc., who will be…
Study Explores Type 1 Diabetes Vaccine
Bioinformatics and Computational Science, Advanced Biomedical Computational SciencePosted 5/18/2023A research collaboration has made early progress toward a potential vaccine for type 1 diabetes, a long-sought goal for an autoimmune disease that affects more than 1.5 million Americans.
The team, including Frederick National Laboratory computational scientist David Bell, previously discovered a new protein antibody in type 1 diabetes patients. The antibody, X-idiotype,…
Investigating the Immune Response to SARS-CoV-2
Vaccine, Immunity, and Cancer DirectoratePosted 5/11/2023A new test detects exposure to viruses that cause COVID-19 and their relatives. Research using it could aid efforts to protect against infections.
A team at the Frederick National Laboratory for Cancer Research developed a test capable of assessing exposure to the virus that causes COVID-19 and to a selection of its variants and viral relatives, all from a minute amount…
Vaccine tested for malaria and other mosquito-borne diseases
Clinical Monitoring Research ProgramPosted 5/5/2023A research group that includes scientists from the Frederick National Laboratory for Cancer Research has shown that an experimental vaccine designed to simultaneously protect against malaria, Zika, and a host of other mosquito-borne diseases safely provokes a strong immune response when tested in human volunteers. The next step will be to see if the vaccine blocks infection in…
Canine data commons lets dogs with cancer help humans
Bioinformatics and Computational SciencePosted 4/26/2023
Dogs and humans have been companions throughout recorded history. Our four-legged friends appear in early written tales, such as the Mesopotamian poem The Epic of Gilgamesh, and are mentioned by name in ancient Egyptian inscriptions. In prehistoric gravesites worldwide, dogs are found laid to rest alongside humans. They’ve been with us through thick and thin, and we have…
AI predicts the aggressiveness of a childhood cancer
Bioinformatics and Computational SciencePosted 4/18/2023By training computer models to assess pathology images of rhabdomyosarcoma tumors, researchers hope to help doctors better tailor treatments to patients.
Researchers at the Frederick National Laboratory for Cancer Research and the National Cancer Institute developed an artificial intelligence-based system that can anticipate the severity of cases of a childhood cancer…
Media Inquiries
For all media related questions please contact:
Mary Ellen Hackett
Manager, Communications Office